Meta-level question: how do you evaluate evidence for drostanolone propionate when the human data is thin and most trials are small?
Baseline first. Without a baseline the after picture is decoration.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took two months to be sure.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
Estrogen management is overcorrected far more often than it is undercorrected.
What would change your mind about this?
If it needs three other compounds to notice, you have not tested the first one.
Same here.
Water retention was my main issue with drostanolone propionate too.
A plausible mechanism is not an outcome, and this class is the textbook example. Currently on drostanolone propionate myself.
Nobody has ever been talked out of a stack by a stranger on the internet.
What is the first thing you would read if you were starting from zero?